Evidence map›Paper›PMID 30649582›Full record

ReviewDer Urologe. Ausg. A2019

[Instillation therapies for urothelial carcinoma of the upper urinary tract].

P Bosshard, G N Thalmann, B Roth

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

P BosshardUrologische Universitätsklinik, Inselspital, Universitätsspital Bern, 3010, Bern, Schweiz.
G N ThalmannUrologische Universitätsklinik, Inselspital, Universitätsspital Bern, 3010, Bern, Schweiz. George.Thalmann@insel.ch.
B RothUrologische Universitätsklinik, Inselspital, Universitätsspital Bern, 3010, Bern, Schweiz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditionally, urothelial carcinoma of the upper urinary tract was a clear indication for radical nephroureterectomy with bladder cuff excision. It has been shown that in well-selected patients and depending on tumor stage, a kidney-sparing approach can be pursued with good oncological outcome and equivalent to the radical approach. The prevention of local and bladder recurrences is an important factor. Instillation therapies with bacillus Calmette-Guérin and/or mitomycin C have been successfully used to this end. Due to the low incidence of upper tract urothelial cancer and due to the usually retrospective nature of existing literature, however, data is limited. In this article, we provide a review of the indication, technical execution and results of instillation therapies of the upper urinary tract.

Indexed as

Carcinoma in SituAdministration, IntravesicalAgedCarcinoma, Transitional CellCystectomyFemaleHumansInstillation, DrugKidneyMaleNeoplasm Recurrence, LocalRetrospective StudiesUreterUreteral NeoplasmsUrinary BladderUrinary TractBacillus Calmette-GuérinCarcinoma in situMitomycin CNephroureterectomyVesico-ureteral reflux

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.